Atlas Trials

A Prolongation of a Clinical Study to Evaluate the Efficacy of an Aqueous Gel Containing 2% (w/w) of Cidofovir, Directly Applied on the Cervix Exhibiting High Grade Squamous Intraepithelial Lesions.

Clinical trial NCT02976987 · COMPLETED

Trial details

NCT number
NCT02976987
Sponsor
Brugmann University Hospital
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
High Grade Cervical Epithelial Neoplasia (CIN2+)
Start date
2013-02-01
Primary completion
2016-04-01
Enrollment
36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.